BillionToOne Inc
NASDAQ:BLLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BillionToOne Inc
NASDAQ:BLLN
|
US |
|
Roblon A/S
CSE:RBLN B
|
DK |
|
B
|
Black Pearl SA
WSE:BPC
|
PL |
|
Par Drugs and Chemicals Ltd
NSE:PAR
|
IN |
BillionToOne Inc
BillionToOne Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Menlo Park, California. The company went IPO on 2025-11-06. BillionToOne Inc is a United States-based precision diagnostics company. The firm provides Quantitative Counting Template (QCT) molecular counter platform, is the only technology platform that can count deoxyribonucleic acid (DNA) molecules to the single-count level and detect risk for common and severe genetic diseases. The Company’s product UNITY, is a noninvasive prenatal screening that tests fetal cell-free DNA for cystic fibrosis (CF) and spinal muscular atrophy (SMA) through a single sample of the mother's blood.
BillionToOne Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Menlo Park, California. The company went IPO on 2025-11-06. BillionToOne Inc is a United States-based precision diagnostics company. The firm provides Quantitative Counting Template (QCT) molecular counter platform, is the only technology platform that can count deoxyribonucleic acid (DNA) molecules to the single-count level and detect risk for common and severe genetic diseases. The Company’s product UNITY, is a noninvasive prenatal screening that tests fetal cell-free DNA for cystic fibrosis (CF) and spinal muscular atrophy (SMA) through a single sample of the mother's blood.
